PCSK9 inhibition & CV events: review of recent and upcoming hard endpoint outcome trials.
26 August 2017 (16:05 - 16:25)
Organised by:
About the speaker
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
4 More presentations in this session
Doctor M. Farnier (Dijon, FR)
Professor J. Chapman (Paris, FR)
Doctor G. Hovingh (Amsterdam, NL)
Professor W. Koenig (Munich, DE)
Doctor M. Farnier (Dijon, FR)
Access the full session
The Event
ESC Congress 2017
26 August 2017
16:05 CET
You may be interested in
Congress Presentation
Webinar
19 April 2024
Congress Presentation
